Based in part on our prior studies [13,16,39], we predict that the balance between SUMOylated and phosphorylated (that is, deSUMOylated) PRs is frequently altered in breast cancer, resulting in changes in PR promoter selectivity and altered patterns of gene expression. This evidence concerns the gene WNK3 and breast cancer.